N-acetyl cysteine improves affinity of beta-tricalcium phosphate granules for cultured osteoblast-like cells
Authors:
- 28 September 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 27 (1) , 27-36
Abstract
Enhancement of bone substitute's biocompatibility may accelerate healing of surrounding bone. Although widely used as a biodegradable alloplastic bone substitute for alveolar bone augmentation, the osteocompatibility of beta-tricalcium phosphate (β-TCP) remains to be proven. The adverse cellular response to biomaterials is associated with oxidative stress. We hypothesized that commercially available β-TCP granules for clinical use, caused oxidative stress and was not optimal in osteocompatibility and that application of antioxidant amino acid derivative N-acetyl cysteine (NAC) would improve osteoblastic responses to the material. Only 20% of rat calvarial osteoblasts cultured on β-TCP granules remained viable at 24 h after seeding as opposed to 90% on polystyrene. Cell death on β-TCP granules was characterized by necrosis. However, the percentage of viable osteoblasts cultured on β-TCP granules showed a 100% increase with pre-treatment with NAC. NAC restored suppressed alkaline phosphatase activity on β-TCP granules at day 5. Intracellular ROS level on β-TCP granules was 16-fold greater than that on polystyrene, but decreased by half with pre-treatment with NAC. Cell death and intracellular ROS elevation were also induced in polystyrene culture under β-TCP granules even when the osteoblasts were not in direct contact with the β-TCP granules. NAC, however, prevented induction of cell death and elevation of intracellular ROS under β-TCP granules. These results indicate that commercially available β-TCP granules negatively affect cultured osteoblastic viability and function via oxidative stress and that NAC improves these negative responses to the material. This implies enhanced bone regeneration around biodegradable calcium phosphate-based bone substitute by NAC.Keywords
This publication has 53 references indexed in Scilit:
- Evaluation by Bone Scintigraphy of Osteogenic Activity of Commercial Bioceramics (Porous β-TCP and HAp Particles) Subcutaneously Implanted in RatsJournal of Biomaterials Applications, 2009
- N-acetyl cysteine (NAC)-mediated detoxification and functionalization of poly(methyl methacrylate) bone cementBiomaterials, 2009
- A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and β-TCP ceramicsBiomaterials, 2008
- Review Paper: Behavior of Ceramic Biomaterials Derived from Tricalcium Phosphate in Physiological ConditionJournal of Biomaterials Applications, 2008
- Calcium orthophosphate cements for biomedical applicationJournal of Materials Science, 2008
- Histological and histomorphometrical comparative study of the degradation and osteoconductive characteristics of α‐ and β‐tricalcium phosphate in block graftsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- The Cytocompatibility and Early Osteogenic Characteristics of an Injectable Calcium Phosphate CementTissue Engineering, 2007
- Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb®) for bone regeneration in the reconstructive surgery of the jawsInternational Journal of Oral and Maxillofacial Surgery, 2006
- Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in α-MEM and in DMEMBiomaterials, 2000
- The effect of calcium phosphate ceramic composition and structure on in vitro behavior. I. DissolutionJournal of Biomedical Materials Research, 1993